+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

OpinionOpen Access

Biomedical Prospects for The Use of Stem Cells for The Treatment of Gliomas

Volume 4 - Issue 5

Vladimir Kulchitsky*1 and Stanislav Koulchitsky2

  • Author Information Open or Close
    • 1Institute of Physiology, National Academy of Sciences, Belarus
    • 2Institute of Physiology, University of Liège, Belgium

    *Corresponding author: Vladimir Kulchitsky, Scientific Director, Institute of Physiology, National, Academy of Sciences of Belarus, 28 Akademicheskaya Street, Minsk 220072, Belarus, Tel.: +375-17-2842458 ; Fax: +375-17-2841630, Email:

Received: May 23, 2018;   Published: May 29, 2018

DOI: 10.26717/BJSTR.2018.04.001119

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


Low efficiency of classic antitumor therapy initiates search for new ways of early diagnostics, prophylaxis and treatment of tumors. Specialists sometimes pay attention to extraordinary strategies based, for example, on the use of stem cells (SC) as specific biological agents aimed at destruction of malignant gliomas [1-3]. These technologies are the result of stem cells fundamental ability to migrate to brain tumors penetrating through blood-brain barrier [1].

Abbrevations: MiRs: MicroRNAs, SCs: Stem Cells, TNF-α: Tumor Necrosis Factor

Introduction| Stem cells and malignant glioma cells| Contradictions in the technique of stem cells implantation in brain tumors| Conclusion| Acknowledgement| References|